Vacunas contra el SARS-CoV-2: ¿son una realidad para América Latina?
Biomedica. 2020 09 01; 40(3):424-426.B

Links

Authors+Show Affiliations

Department of Microbiology and Immunology, Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX, USA. altorres@utmb.edu.

Pub Type(s)

Editorial

Language

spa

PubMed ID

33030819

Citation

Torres, Alfredo G.. "" Biomedica : Revista Del Instituto Nacional De Salud, vol. 40, no. 3, 2020, pp. 424-426.

Torres AG. Biomedica. 2020;40(3):424-426.

Torres, A. G. (2020). Biomedica : Revista Del Instituto Nacional De Salud, 40(3), 424-426. https://doi.org/10.7705/biomedica.5826

Torres AG. . Biomedica. 2020 09 1;40(3):424-426. PubMed PMID: 33030819.

* Article titles in AMA citation format should be in sentence-case

TY - JOUR T1 - A1 - Torres,Alfredo G, Y1 - 2020/09/01/ PY - 2020/09/25/received PY - 2020/10/8/entrez PY - 2020/10/9/pubmed PY - 2020/10/23/medline SP - 424 EP - 426 JF - Biomedica : revista del Instituto Nacional de Salud JO - Biomedica VL - 40 IS - 3 SN - 2590-7379 UR - https://www.unboundmedicine.com/medline/citation/33030819/ DB - PRIME DP - Unbound Medicine ER -

Tags

Vacunas contra el SARS-CoV-2: ¿son una realidad para América Latina?Biomedica. 2020 09 01; 40(3):424-426.B